You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Mallinckrodt
Baxter
McKinsey
McKesson

Last Updated: October 1, 2020

DrugPatentWatch Database Preview

Patent: 6,942,614

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,942,614
Title: Method and system for use in treating a patient with an anticoagulant to optimize therapy and prevent an adverse drug response
Abstract:A method and system for use in treating a patient receiving an anticoagulant or a substance containing warfarin to optimize therapy and prevent an adverse drug response. This system employs surrogate markers or indicators including blood levels of the anticoagulant to determine the next required dose for a patient. Since the surrogate markers are employed as a percent change in status, virtually any indicator can be used. Surrogate markers could include any measure of the effectiveness of the anticoagulant\'s action. Given the effectiveness of the anticoagulant\'s action relative to the surrogate markers, a change in anticoagulant dose is calculated by the system. Conversely, by employing this system, one could determine the expected result of the anticoagulant dose change on the surrogate markers.
Inventor(s): Kutzko; John D. (Nokomis, FL), Singer; Michaeal G. (Harrisville, MI), McMichael; John (Wexford, PA)
Assignee: Dimensional Dosing Systems, Inc. (Wexford, PA)
Application Number:09/644,503
Patent Claims:see list of patent claims

Details for Patent 6,942,614

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Ekr Therap RETAVASE reteplase VIAL 103786 001 1998-05-06   Start Trial Dimensional Dosing Systems, Inc. (Wexford, PA) 2019-07-06 RX search
Genentech CATHFLO ACTIVASE alteplase VIAL 103172 003 1987-11-13   Start Trial Dimensional Dosing Systems, Inc. (Wexford, PA) 2019-07-06 RX search
Genentech ACTIVASE alteplase VIAL; SINGLE-USE 103172 002 1987-11-13   Start Trial Dimensional Dosing Systems, Inc. (Wexford, PA) 2019-07-06 RX search
Genentech ACTIVASE alteplase VIAL; SINGLE-USE 103172 001 1987-11-13   Start Trial Dimensional Dosing Systems, Inc. (Wexford, PA) 2019-07-06 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Merck
AstraZeneca
Colorcon
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.